The global precision medicine market is expected to grow at an estimated CAGR of 10.5% from 2018 to 2029. In the precision medicine market, the Diagnostic Tool companies’ segment is dominating the global market and accounted for $23.36 billion in 2018 due to the development of large number of diagnostic and genetic tests.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 212-page report you will receive 98 tables and 63 figures– all unavailable elsewhere.
The 212-page report provides clear detailed insight into the global precision medicine market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
• Global Precision Medicine Market forecasts from 2019-2029
• Along with revenue prediction for the overall market for the global precision medicine market, our investigation shows forecasts to 2029 for the market segmented by technology:
– Companion Diagnostics
– Biomarker-based Test
– Targeted Therapeutics
– Pharmacogenomics
– Molecular Diagnostics
The report discusses key trends, developments and participants.
• This report breaks down the precision medicine market forecast to 2029 by end-users:
– Pharmaceuticals & Biotechnology Companies
– Diagnostic Companies
– Healthcare IT/Big Data Companies
– Clinical Laboratories
The report discusses key trends, developments and participants.
• This report also breaks down the precision medicine market forecast to 2029 by therapeutic application:
– Cancer
– Cardiovascular Diseases
– Central Nervous System
– Infectious Diseases
– Immunology
– Others
The report discusses key trends, developments and participants.
• This study provides precision medicine market forecasts to 2029 for these regional markets:
– North America: US & Canada
– Europe: Germany, UK, France, Italy, Spain, Rest of Europe
– Asia-Pacific: China, japan, India, Australia, South Korea, Rest of Asia-Pacific
– Middle East & Africa: South Africa, Saudi Arabia, Rest of Middle East & Africa
– Latin America: Brazil, Mexico, Rest of Latin America
For each regional market, the report discusses key trends, developments and participants.
• This report profiles selected leading companies that are the main players in the global precision medicine market:
– Abbott
– Danaher Corporation
– GE Healthcare
– GlaxoSmithKline
– Illumina, Inc.
– Johnson & Johnson
– Laboratory Corporation of America Holdings
– Novartis
– Pfizer
– QIAGEN
– Thermo Fisher Scientific, Inc.
• Our study discusses the drivers, restraints as well as the opportunities in the global precision medicine market.
• This study also analyzed the global precision medicine market with Porter’s Five Forces Analysis as well as Value Chain Analysis
• This report discusses selected market developments in the precision medicine market: partnership, collaboration, join venture, acquisitions, product launch, product development, expansions, patents, approvals.
Visiongain’s study is intended for anyone requiring commercial analyses for the global precision medicine market. You find data, trends and predictions.
Buy our report today Global Precision Medicine Market Forecast 2019-2029: Companion Diagnostics, Biomarker-based Test, Targeted Therapeutics, Pharmacogenomics, Molecular Diagnostics, Pharmaceuticals & Biotechnology Companies, Diagnostic Companies, Healthcare IT/Big Data Companies, Clinical Laboratories, Cancer, Cardiovascular Diseases, Central Nervous System, Infectious Diseases.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1 Global Precision Medicine Market Overview
1.1.1 Precision Medicine Market – Segmentation by Technology
1.1.2 Precision Medicine Market – Segmentation by End Users
1.1.3 Precision Medicine Market – Segmentation by Therapeutic Application
1.1.4 Precision Medicine Market – Segmentation by Geography
1.2 Why You Should Read This Report
1.3 How This Report Delivers
1.4 Key Questions Answered by This Analytical Report Include
1.5 Who is This Report For?
1.6 Methodology
1.6.1 Primary Research
1.6.2 Secondary Research
1.6.3 Market Evaluation & Forecasting Methodology
1.7 Frequently Asked Questions (FAQ)
1.8 Associated Visiongain Reports
1.9 About Visiongain
2. Introduction to Precision Medicine
2.1 Evolution and Brief History of Precision Medicine
2.2 Key Benefits of Precision Medicine
2.3 Precision Medicine: Key Areas of Application
2.4 Precision Medicine: Key Elements
2.5 Precision Medicine: Different Type of Data Used by Big Data Companies
2.6 Precision Medicine: Area of Interest
3. Global Precision Medicine Market 2019-2029
3.1 Global Precision Medicine Market by End-Users, 2019-2029
3.2 Global Precision Medicine Market by Technology, 2019-2029
3.3 Global Precision Medicine Market by Therapeutic Application, 2019-2029
3.4 Global Precision Medicine Market by Geography, 2019-2029
4. Market Dynamics
4.1 Global Precision Medicine Market Drivers
4.1.1 Upcoming Technologies in Healthcare
4.1.2 Collaboration of Big Data Companies with Pharma & Biotech Companies
4.1.3 Greater Involvement in Personal Healthcare
4.1.4 A Rise in Genetic Diseases
4.1.5 Growing Demand for Targeted Therapies
4.2 Global Precision Medicine Market Restraints
4.2.1 Limitations in Application due to Lack of Research and Evidences
4.2.2 Stringent Regulatory Framework and Reimbursement Policies
4.2.3 Stringent Regulations and Standards
4.2.4 Higher Cost of Diagnostics
4.2.5 Risk to Personal Data
4.2.6 Risk of failure of Software or Hardware
4.2.7 Lack of Knowledge and Awareness
4.3 Global Precision Medicine Market Opportunities
4.3.1 Increasing Awareness in Developing Economies
4.3.2 Reduction in the cost of Genome Sequencing
4.4 Regulatory Bodies
4.4.1 Food and Drug Administration (FDA)
4.4.2 Medicines and Healthcare Products Regulatory Agency (MHRA)
4.4.3 Therapeutic Goods Administration (TGA)-Australia
4.4.4 Conformité Européenne (CE)
4.5 Consortiums
4.6 Alliances/Associations
5. Global Precision Medicine Market Forecast 2019-2029 - Segmented by End-Users
5.1 Introduction
5.1.1 Global Precision Medicine Market Forecast 2019-2029: Segmented by End-Users
5.2 Global Pharmaceuticals and Biotechnology Companies Submarket Forecast 2019-2029
5.2.1 Key Market Trends, Developments and Participants
5.2.1.1 Market Trends
5.2.1.2 Market Developments
5.2.1.3 Key Participants
5.3 Global Diagnostic Tools Companies Submarket Forecast 2019-2029
5.3.1 Key Market Trends, Developments and Participants
5.3.1.1 Market Trends
5.3.1.2 Market Developments
5.3.1.3 Key Participants
5.4 Global Healthcare IT Specialists/ Big Data Companies Submarket Forecast 2019-2029
5.4.1 Key Market Trends, Developments and Participants
5.4.1.1 Market Trends
5.4.1.2 Market Developments
5.4.1.3 Key Participants
5.5 Global Clinical Laboratories Submarket Forecast 2019-2029
5.5.1 Key Market Trends, Developments and Participants
5.5.1.1 Regulatory bodies and compliances
5.5.1.2 Market Trends
5.5.1.3 Key Participants
6. Global Precision Medicine Market Forecast 2019-2029 - Segmented by Technology
6.1 Introduction
6.1.1 Global Precision Medicine Market Forecast 2019-2029: Segmented by Technology
6.2 Global Companion Diagnostics Submarket Forecast 2019-2029
6.3 Global Biomarkers Submarket Forecast 2019-2029
6.3.1 Role of Biobanking in Biomarker
6.3.2 Key Participants
6.4 Global Biobanking in Targeted Therapeutics Submarket Forecast 2019-2029
6.4.1 Key Participants
6.5 Global Pharmacogenomics Submarket Forecast 2019-2029
6.5.1 Key Market Trends, Developments and Participants
6.5.1.1 Market Trends
6.5.1.2 Market Developments
6.5.1.3 Key Participants
6.6 Global Molecular Diagnostics Submarket Forecast 2019-2029
7. Global Precision Medicine Market Forecast 2019-2029: Segmented by Therapeutic Application
7.1 Introduction
7.1.1 Global Precision Medicine Market Forecast 2019-2029: Segmented by Therapeutic Application
7.2 Global Cancer Submarket Forecast 2019-2029
7.2.1 Types of Cancer
7.2.2 Key Market Trends, Developments & Participants
7.2.2.1 Market Trends
7.2.2.2 Market Developments
7.2.2.3 Key Participants
7.3 Global Cardiovascular Disease (CVD) Submarket Forecast 2019-2029
7.3.1 Drugs & Tests
7.3.2 Market Trends & Market Developments
7.3.2.1 Market Trends
7.3.2.2 Market Developments
7.3.2.3 Key Participants
7.4 Global Central Nervous System (CNS) Market Forecast 2019-2029
7.4.1 Neurological
7.4.1.1 Neurological Drugs & Tests
7.4.2 Psychiatric Disorders
7.4.2.1 Psychiatric Disorder Drugs & Tests
7.4.3 Market Trends & Market Developments
7.4.3.1 Market Trends
7.4.3.2 Key Participants
7.5 Global Infectious Diseases Submarket Forecast 2019-2029
7.5.1 Infectious Diseases Drugs & Tests
7.5.2 Market Developments & participants
7.5.2.1 Key Developments
7.5.2.2 Key Participants
7.6 Global Immunology Market Forecast 2019-2029
7.6.1 Market Trends
7.6.1.1 Market Trends
7.7 Global Other Therapeutic Application Submarket Forecast 2019-2029
7.7.1 Market Trends, Developments & Participants
7.7.1.1 Market Trends
7.7.1.2 Key Developments
7.7.1.3 Key Participants
8 Global Precision Medicine Market Forecast 2019-2029 – Segmented by Geography
8.1 Introduction
8.2 North America Precision Medicine Market Forecast 2019-2029
8.2.1 U.S.
8.2.1.2 Canada
8.2.1.3 Key Market Trends, Developments and Participants
8.2.1.3.1 Regulations and Compliances
8.2.1.3.2 Market Trends
8.2.1.3.3 Market Developments
8.2.1.4 Key Participants
8.3 Europe Precision Medicine Market Forecast 2019-2029
8.3.1 Key Market Trends, Developments and Participants
8.3.1.1 Regulations and Compliances
8.3.1.2 Market Developments
8.3.1.3 Key Participants
8.4 Asia-Pacific (APAC) Precision Medicine Market Forecast 2019-2029
8.4.1 Key Market Trends, Developments and Participants
8.4.1.1 Market Developments
8.4.1.2 Key Participants
8.5 Middle East & Africa Precision Medicine Market Forecast 2019-2029
8.5.1 Key Market Developments and Participants
8.5.1.1 Market Developments
8.5.1.2 Key Participants
8.6 Latin America Precision Medicine Market Forecast 2019-2029
8.6.1 Key Market Developments and Participants
8.6.1.1 Market Developments
8.6.1.2 Key Participants
9. Market Analysis
9.1 Porter’s Five Forces Analysis
9.1.1 Bargaining Power of Suppliers
9.1.2 Bargaining Power of Buyer
9.1.3 Industry Rivalry
9.1.4 Threat of New Entrants
9.1.5 Threat of Substitutes
9.2 Value Chain Analysis
9.2.1 Device Manufacturer & Drug Producers
9.2.2 Healthcare Providers
9.2.3 Healthcare IT Or Big Data Companies
9.2.4 Regulators
9.2.5 Third Party Payers
9.2.6 Patients
10. Company Profiles
10.1 Abbott Laboratories: Overview
10.1.1 Abbott Laboratories: Products & Service
10.1.2 Abbott Laboratories: Key Developments
10.1.3 Abbott Laboratories: Future Outlook and Growth Strategy
10.2 GE Healthcare: Overview
10.2.1 GE Healthcare: Products & Service
10.2.2 GE Healthcare: Key Developments
10.2.3 GE Healthcare: Future Outlook and Growth Strategy
10.3 GlaxoSmithKline plc: Overview
10.3.1 GlaxoSmithKline plc: Products & Service
10.3.2 GlaxoSmithKline plc: Future Outlook and Growth Strategy
10.4 Johnson & Johnson: Overview
10.4.1 Johnson & Johnson: Products & Service
10.4.2 Johnson & Johnson: Key Developments
10.4.3 Johnson & Johnson: Future Outlook and Growth Strategy
10.5 Pfizer Inc.: Overview
10.5.1 Pfizer Inc.: Products & Service
10.5.2 Pfizer Inc.: Key Developments
10.5.3 Pfizer Inc.: Future Outlook and Growth Strategy
10.6 Laboratory Corporation of America Holdings Overview
10.6.1 Laboratory Corporation of America Holdings: Products & Service
10.6.2 Laboratory Corporation of America Holdings: Key Developments
10.7 Danaher Corporation: Overview
10.7.1 Danaher Corporation: Products & Service
10.7.2 Danaher Corporation: Key Developments
10.8 QAGEN: Overview
10.8.1 QIAGEN: Products & Service
10.9 Thermo Fisher Scientific, Inc.: Overview
10.9.1 Thermo Fisher Scientific: Products & Service & Recent Developments
10.10 Illumina, Inc.: Overview
10.10.1 Illumina, Inc.: Products & Service & Recent Developments
10.11 Novartis AG: Overview
10.11.1 Novartis AG: Recent Developments
11. Competitive Landscape
11.1 Introduction
11.1.1 Partnerships, Collaborations and Joint Ventures
11.1.2 Product Launch/Development
11.1.3 Acquisitions
11.1.4 Expansion
11.1.5 Patents, Approvals and Certifications
11.1.6 Others
Appendices
Associated Visiongain Reports
Visiongain Report Sales Order Form
About Visiongain
Visiongain Report Evaluation Form
List of Tables
Table 2.1 Key Benefits of Precision Medicine
Table 2.2 Key Elements of Precision Medicine
Table 4.1 Key Benefits of Precision Medicine for Patients
Table 4.2 Key Laws & Regulatory Bodies in the Precision Medicine Industry
Table 4.3 Key Consortiums in the Precision Medicine Industry
Table 4.4 Key Alliances/Associations in the Precision Medicine Industry
Table 5.1 Global Precision Medicine Market Forecast by End-Users: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 5.2 Global Pharma & Biotech Companies End User Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 5.3 Key Developments in Pharma & Biotech Companies
Table 5.4 Global Diagnostic Tool Companies End User Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 5.5 Key Developments in Diagnostic Companies
Table 5.6 Global Healthcare ITs/Big Data End User Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 5.7 Key Developments in Healthcare IT/Big Data Companies
Table 5.8 Global Clinical Laboratories Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 6.1 Global Precision Medicine Market by Technology: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 6.2 Global Companion Diagnostics Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 6.3 List of Approved Companion Diagnostic Devices
Table 6.4 Global Biomarkers Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 6.5 List of Biobanks
Table 6.6 Examples of Biobanking Initiatives Across Selected OECD Countries
Table 6.7 Global Biobanking in Targeted Therapeutics Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 6.8 Global Pharmacogenomics Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 6.9 Market Developments
Table 6.10 Global Molecular Diagnostics Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 6.11 Some Examples of Human Genetic Tests That Have Been Approved by the FDA
Table 6.12 Some Examples of Microbial Tests That Have Been Approved by the FDA
Table 7.1 Global Precision Medicine Therapeutic Application Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 7.2 Global Cancer Therapeutic Application Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 7.3 Precision Medicine Drugs and Relevant Genes: Oncology
Table 7.4 Precision Medicine Genetic Tests with Respect to Oncology
Table 7.5 Key Developments
Table 7.6 Global Cardiovascular Therapeutic Application Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 7.7 Precision Medicine Drugs and Relevant Genes: Cardiovascular
Table 7.8 Precision Medicine Genetic Tests with Respect to Cardiovascular
Table 7.9 Key Developments
Table 7.10 Global CNS Therapeutic Application Market: Revenue ($bn), AGR (%), CAGR (%) 2018-2029
Table 7.11 Precision Medicine Drugs and Relevant Genes: Neurology
Table 7.12 Precision Medicine Drugs and Relevant Genes: Psychiatric Disorders
Table 7.13 Precision Medicine Genetic Tests with Respect to Psychiatric Disorders
Table 7.14 Psychiatric Disorders: Key Developments
Table 7.15 Global Infectious Disease Therapeutic Application Market: Revenue ($bn), AGR (%), CAGR (%) 2018-2029
Table 7.16 Precision Medicine Drugs and Relevant Genes: Infectious Diseases
Table 7.17 Key Developments
Table 7.18 Global Immunology Therapeutic Application Market: Revenue ($bn), AGR (%), CAGR (%) 2018-2029
Table 7.19 Global Other Therapeutic Application Market: Revenue ($bn), AGR (%), CAGR (%) 2018-2029
Table 7.20 Precision Medicine Drugs and Relevant Genes: Other Diseases
Table 7.21 Precision Medicine Genetic Tests with Respect to Other Diseases
Table 7.22 Key Developments
Table 8.1 Global Precision Medicine Market by Geography: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 8.2 North America Precision Medicine Market by Country: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 8.3 Market Developments
Table 8.4 Europe Precision Medicine Market by Countries: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 8.5 Market Developments
Table 8.6 APAC Precision Medicine Market by Countries: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 8.7 Market Developments
Table 8.8 Middle East & Africa Precision Medicine Market by Countries: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 8.9 Market Developments
Table 8.10 Latin America Precision Medicine Market by Countries: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 8.11 Market Developments
Table 9.1 Key Factors Affecting the Bargaining Power of Suppliers
Table 9.2 Key Factors Affecting the Bargaining Power of Buyer
Table 9.3 Key Factors Affecting the Industry Rivalry
Table 9.4 Key Factors Affecting the Threat of New Entrants
Table 9.5 Key Factors Affecting the Threat of Substitutes
Table 10.1 Abbott Laboratories: Overview
Table 10.2 Abbott Laboratories: 5-year Revenue, Net Income, Operating Income ($ Mn)
Table 10.3 Abbott Laboratories: Key Developments
Table 10.4 GE Healthcare Overview
Table 10.5 GE Healthcare: 5-year Revenue, Profit ($ Mn)
Table 10.6 GE Healthcare: Key Developments
Table 10.7 GlaxoSmithKline plc: Overview
Table 10.8 GlaxoSmithKline plc: 5-year Revenue, Operating Profit, Profit After Tax ($ Mn)
Table 10.9 Johnson & Johnson: Overview
Table 10.10 Johnson & Johnson: 5-year Revenue, Net Earnings ($ Mn)
Table 10.11 Johnson & Johnson: Key Developments
Table 10.12 Pfizer Inc. Overview
Table 10.13 Pfizer Inc.: 5-year Revenue ($ Mn)
Table 10.14 Pfizer Inc: Key Developments
Table 10.15 Laboratory Corporation of America Holdings: Overview
Table 10.16 Laboratory Corporation of America Holdings: 5-year Revenue, Net Income, Operating Income ($ Mn)
Table 10.17 Laboratory Corporation: Key Developments
Table 10.18 Danaher Corporation: Overview
Table 10.19 Danaher Corporation: 5-year Revenue, Net Income, Operating Profit ($ Mn)
Table 10.20 Danaher Corporation: Key Developments
Table 10.21 QIAGEN: Overview
Table 10.22 QIAGEN: 5-year Revenue, Net Income ($ Mn)
Table 10.23 Thermo Fisher Scientific, Inc.: Overview
Table 10.24 Thermo Fisher Scientific, Inc.: 5-year Revenue, Net Income, Operating Income ($ Bn)
Table 10.25 Illumina, Inc.: Overview
Table 10.26 Illumina, Inc.: 5-year Revenue, Net Income, Operating Income ($bn)
Table 10.27 Novartis AG: Overview
Table 10.28 Novartis AG: 3-year Revenue, Net Income, Operating Income ($bn)
Table 11.1 Key Partnerships, Collaborations and Joint Ventures
Table 11.2 Key Product Developments
Table 11.3 Key Acquisitions
Table 11.4 Key Expansion
Table 11.5 Key Patents, Approvals and Certifications
Table 11.6 Key Other Events
List of Figures
Figure 1.1 Global Precision Medicine Market – Segmentation by Technology
Figure 1.2 Global Precision Medicine Market – Segmentation by End Users
Figure 1.3 Global Precision Medicine Market - Segmentation by Therapeutic Application
Figure 1.4 Global Precision Medicine Market - Segmentation by Geography
Figure 2.1 History of Precision Medicine
Figure 2.2 Key Areas of Application for Precision Medicine
Figure 2.3 Key Different Type of Data Used by Big Data Companies in Precision Medicine
Figure 2.4 Key Areas of Interest for Precision Medicine
Figure 3.1 Global Precision Medicine Market Share by End Users: Revenue ($bn), 2018-2029
Figure 3.2 Global Precision Medicine Market Size by Technology: Revenue ($bn), 2018-2029
Figure 3.3 Global Precision Medicine Market Size by Therapeutic Application: Revenue ($bn), 2018-2029
Figure 3.4 Global Precision Medicine Market Size by Geography: Revenue ($bn), 2019-2029
Figure 4.1 Key Difficulties Faced by Players of Precision Medicine Market due to Regulations and Standards
Figure 4.2 FDA’s Role in Precision Medicine
Figure 5.1 Global Precision Medicine Market by End Users
Figure 5.2 Role of Pharmaceuticals and Biotech Companies
Figure 5.3 Challenges Faced by Pharma & Biotech Companies
Figure 5.4 Diagnostic Tests Benefits for Stakeholders
Figure 5.5 Challenges Faced by Diagnostic Companies
Figure 5.6 Benefits of Big Data
Figure 5.7 Transformation of Medicine
Figure 5.8 Basic Ingredients Provided by Big Data for Precision Medicine
Figure 5.9 Challenges Faced by Big Data Companies
Figure 5.10 OECD Recommendations on The Governance of Clinical Trials
Figure 6.1 Types of Precision Medicine Sub-Market
Figure 6.2 Benefits of Companion Diagnostics
Figure 6.3 Function of Biomarkers
Figure 6.4 Biobanks Services
Figure 6.5 Development in PGx
Figure 6.6 Model Systems Used in PGx
Figure 6.7 Challenges of PGx Studies
Figure 6.8 Type of Molecular Diagnostics Test
Figure 6.9 Molecular Diagnostics: Application
Figure 6.10 Molecular Diagnostics: Benefits
Figure 8.1 Global Precision Medicine Market Classification by Geography
Figure 8.2 Key Drivers for Precision Medicine: North America
Figure 8.3 Objectives of the Precision Medicine Initiative
Figure 8.4 APAC: Market Challenges
Figure 9.1 Precision Medicine Market Porter’s Five Forces Analysis, 2018
Figure 9.2 Precision Medicine Market Value Chain
Figure 10.1 Abbott Laboratories: Sales by Business Segment (%), 2018
Figure 10.2 Abbott Laboratories: Sales by Region (%), 2018
Figure 10.3 GE Healthcare: Sales by Business Segment (%), 2017
Figure 10.4 GE Healthcare: Sales by Geography (%), 2017
Figure 10.5 GlaxoSmithKline plc: Sales by Business
Figure 10.6 GlaxoSmithKline plc: Sales by Region (%), 2017
Figure 10.7 Johnson & Johnson: Sales by Business Segment (%), 2017
Figure 10.8 Johnson & Johnson: Sales by Region (%), 2017
Figure 10.9 Pfizer Inc.: Sales by Business Segment (%), 2018
Figure 10.10 Pfizer Inc.: Sales by Region (%), 2018
Figure 10.11 Laboratory Corporation of America Holdings: Sales by Business Segment (%), 2017
Figure 10.12 Laboratory Corporation of America Holdings: Sales by Region (%), 2017
Figure 10.13 Danaher Corporation: Sales by Business Segment (%), 2017
Figure 10.14 Danaher Corporation: Sales by Region (%), 2017
Figure 10.15 QIAGEN: Sales by Business Segment (%), 2018
Figure 10.16 QIAGEN: Sales by Region (%), 2018
Figure 10.17 Thermofisher Scientific, Inc.: Sales by Business Segment (%), 2018
Figure 10.18 Thermofisher Scientific, Inc.: Sales by Region (%), 2018
Figure 10.19 Illumina, Inc.: Sales by Business Segment (%), 2017
Figure 10.20 Illumina, Inc.: Sales by Region (%), 2017
Figure 10.21 Novartis AG: Sales by Business Segment (%), 2018
Figure 10.22 Novartis AG: Sales by Region (%), 2018
Figure 11.1 Precision Medicine Market Key Development Strategies
23andMe
Abbott
Abbott Molecular Inc.
Abcodia
ACS Biomarker
Actelion Pharmaceuticals Ltd.
Advanced Biological Laboratories
Affymetrix, Inc.
Agendia BV
Alacer Corp
Alberta Cancer Research Biobank
Alios BioPharma, Inc.
Almac
Almac Diagnostics
Amgen
Apple
Archimedes
Aspen
Astellas Pharma Inc.
Astrazeneca plc
Astute Medical
Asuragen, Inc.
AT&T
AthenaHealth, Inc.
Aurora
Auspex Pharmaceuticals, Inc.
Avon Longitudinal Study of Parents and Children
BGI Tech Solutions Co., Ltd.
BioFortis
BioGene
bioMerieux, Inc.
Bode Technology Group, Inc.
CareWell Urgent Care
Caris
Celera Diagnostics
Cell & Co Biorepository
Celtics Healthcare
Cepheid
CFR Pharmaceuticals
Ciba-Geigy
Clarient Diagnostic Services, Inc.
Cognizant
Cooperative Human Tissue Network
COPAN
Covance Inc.
Cubist Pharmaceuticals
Daiichi Sankyo Co. ltd.
Dako
Dako Denmark A/S
Dell
Diabeter
Eagle Pharmaceuticals, Inc.
Eli Lilly
Estonian Genome Project
Ferring Pharmaceuticals
Fisher BioServices
Flakka
Foundation Medicine
GE Healthcare
Genome Medicine
Genomic Health
GenoSpace
Gen-Probe, Inc.
GlaxoSmithKline (GSK)
Glooko
Google Inc.
Hologic, Inc.
Human Tissue Resource Network
HUNT Biobank
IBM
Idera Pharmaceuticals Inc.
Illumina, Inc.
Immuneering Corporation
Infectio Diagnostic, Inc.
Institutional Biobank of Lausanne
Intel
Intomics
Janssen Biotech Inc.
Japan Post Group
Johnson & Johnson
Kaiser Permanente
Lab-Ally LLC
Laboratory Corporation of America
LG
Life Technologies
llumina Inc.
Luminex Molecular Diagnostics Inc.
Lutron Electronics
Mayo Clinic
Medpace
Medtronic
Medtronic plc
Merck
Modul-Bio
Molecular Health
Monogram Bioscience
Myriad Genetic Laboratories, Inc.
Nanosphere, Inc.
NanoString
NextWave
Novartis
Omnyx, LLC
OncoMed Pharmaceuticals, Inc.
Oncotype DX
OneMedNet Corporation
Oracle Healthcare
Panasonic Healthcare
PATH Biobank
Pfizer
Philips Healthcare
ProMedDx
Q2 Solutions
Qiagen
Qiagen Manchester, Ltd.
Qualcomm
Qualcomm Life, Inc.
Quest Diagnostics
Randox Laboratories
Randox Toxicology
Reddy Laboratories
Roche
Roche Molecular Systems, Inc.
Royal Philips
Samsung
Sandoz
Sanofi Aventis
Sanofi Pharma
Siemens Clinical Lab
Siemens Healthcare
Signature Diagnostics AG
St. Jude Medical (SJM)
Sterand Plc
Syapse
Sysmex
Sysmex Corporation
Takeda Pharmaceuticals
Teva Pharmaceuticals
Therascreen
Topera, Inc
Trofile
U.K. Biobank
UMass Cancer Center Tissue and Tumor Bank
Ventana Medical Systems, Inc.
Veropharm
Vysis
Zinfandel Pharmaceuticals
List of Organizations Mentioned in the Report
Alberta Health Services
Alberta Tumour Bank
American Association for Cancer Research (AACR)
American Medical Association
American National Standards Institute (ANSI)
American Telemedicine Association
Association for Molecular Pathology
Beth Israel Deaconess Medical Center (BIDMC)
Biobank Japan-Riken Institute
Biobanque de Picardie
Biological Resources Centres
Canadian Biosample Repository
Canadian Federal Government
Canadian Institutes of Health Research (CIHR)
Cancer Research Network of the FRSQ
Capital Health/Regional Tissue Bank
Careggi University Hospital
Central Biomaterial Bank
Centre for Disease Control and Prevention (CDC)
Charité-Universitätsmedizin Berlin
Confederation of Cancer Biobanks
Danubian Biobank Consortium Tissue Bank
Drug Enforcement Agency (DEA)
European Association for Cancer Research (EACR)
European Diagnostics Manufacturers Association (EDMA)
European Federation of Pharmaceutical Industries and Associations (EFPIA)
European Medicines Agency (EMA)
European Society of Human Genetics
Food and Drug Administration (FDA)
Genethon DNA and Cell Bank
German Heart Failure Network
Global Medical Technology Alliance (GMTA)
Health Science Research Resources Bank/Japan Health Science Foundation
Healthcare information and management systems society (HIMSS)
International Human Genome Sequencing Consortium
International Medical Device Regulators Forum (IMDRF)
Japan National Cancer Center Brain Bank for Aging Research
Japanese Collection of Research Bioresources
King’s College Infectious Diseases Biobank
Liverpool Tissue Bank
Manitoba Breast Tumour Bank
National Institutes of Health (NIH)
NHS Cod Blood Bank
Norwegian University of Science and Technology
Office of the national coordinator for health information technology (ONC HIT)
Ohio State University
Ontario Cancer Research Network
Organization of European Cancer Institute (OECI)
Patient DNA collection at Institute of Human Genetics Heidelberg
Patient-Centered Outcomes Research Institute (PCORI)
Pharmaceutical and medical devices agency (PMDA)
PROCURE Quebec Prostate Cancer
Southwest France Tumour Bank
The Brain Tumour Tissue Bank
The Center for Assessment Technology and Continuous Health (CATCH)
The National Center for Toxicological Research (NCTR)
The National Health Services (NHS)
The National Institute for Health Research (NIHR)
Therapeutic Goods Administration (TGA)
Triangle Global Health Consortium
Tumour Bank of Provence
U.K. Biobank Roslin Wellcome Trust Tick Cell Biobank
U.K. DNA Banking Network
U.K. Stem Cell Bank
United Kingdom Clinical Research Network (UKCRN)
University Hospital of Lausanne and University of Lausanne
University of Bristol
University of Massachusetts Medical School
University of Tartu
Wireless-Life Sciences Alliance (WLSA)
World Health Organisation (WHO)
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
